The Use of Dexmedetomidine in Pediatric Cardiac Surgery
- 1 July 2006
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Anesthesia & Analgesia
- Vol. 103 (1), 52-56
- https://doi.org/10.1213/01.ane.0000217204.92904.76
Abstract
We tested dexmedetomidine, an alpha2 agonist, for its ability to decrease heart rate, arterial blood pressure, and neuroendocrinal responses during pediatric cardiac surgery. In a randomized, placebo-controlled study, 30 pediatric patients undergoing open heart surgery were randomly assigned to one of two equal groups. The control group received saline, whereas the treatment group (DEX group) received an initial bolus dose of dexmedetomidine (0.5 microg/kg) over 10 min, followed immediately by a continuous infusion of 0.5 microg.kg(-1).h(-1). Arterial blood pressure, heart rate, and sequential concentrations of circulating cortisol, epinephrine, norepinephrine, and blood glucose were measured. Relative to baseline, arterial blood pressure and heart rate decreased significantly after the administration of dexmedetomidine through skin incision. In the control group, patients' heart rate and arterial blood pressure measures increased after skin incision until the end of bypass (P < 0.05). In both groups, plasma cortisol, epinephrine, norepinephrine, and blood glucose increased significantly relative to baseline, after sternotomy, and after bypass. However, the values were significantly higher in the control group compared with the DEX group (P < 0.05). In conclusion, intraoperative dexmedetomidine infusion attenuated the hemodynamic and neuroendocrinal response to surgical trauma and cardiopulmonary bypass in pediatric patients undergoing corrective surgery for congenital heart disease.This publication has 16 references indexed in Scilit:
- Effects of clonidine on the pituitary hormonal response to pelvic surgeryBritish Journal of Anaesthesia, 1997
- Acute Metabolic Effects of Clonidine and Adenosine in ManHormone and Metabolic Research, 1993
- Effects of Intravenous Dexmedetomidine in HumansAnesthesiology, 1992
- Responses of Plasma Adrenocorticotropic Hormone, Cortisol, and Cytokines during and after Upper Abdominal SurgeryAnesthesiology, 1992
- Effects of Dexmedetomidine, a Novel Imidazole Sedative-Anesthetic Agent, on Adrenal SteroidogenesisAnesthesia & Analgesia, 1991
- Central α2-adrenoceptors are highly stereoselective for dexmedetomidine, the dextro enantiomer of medetomidineEuropean Journal of Pharmacology, 1991
- Effects of dexmedetomidine, a selective α2-adrenoceptor agonist, on hemodynamic control mechanismsClinical Pharmacology & Therapeutics, 1989
- Characterization of the selectivity, specificity and potency of medetomidine as an α2-adrenoceptor agonistEuropean Journal of Pharmacology, 1988
- Sedative and cardiovascular effects of medetomidine, a novel selective alpha 2‐adrenoceptor agonist, in healthy volunteers.British Journal of Clinical Pharmacology, 1987
- A sensitive enzyme immunoassay for plasma cortisolClinica Chimica Acta; International Journal of Clinical Chemistry, 1980